2025 Call for Applications is Open!
IDSA is pleased to announce a Request for Applications for the Microbial Pathogenesis in Alzheimer’s Disease Research Grant Program for 2025.
The deadline to apply is January 10, 2025 at 11:59 PM EST.
This year funding will be focused on expanding on research that has shown promise in the field of pathogenic causes of Alzheimer’s Disease and will be given to existing researchers to further their work as well as provide support for alignment between established researchers to foster collaborative discovery.
- Both members and non-members of IDSA are encouraged to apply. This includes established investigators and academic and health professionals in all disciplines and health-related professions.
- PhDs and MDs are encouraged to apply.
- Interdisciplinary research is encouraged, including collaborations between experts in Alzheimer’s research and infectious diseases.
- Clinical and basic scientists are encouraged to apply.
- International applicants and non-U.S. citizens are eligible to apply.
Please see FAQ page and review the RFA for more information.
View Informational Webinar recording.
Overview
After 100 years of research, we still do not have a cure for Alzheimer’s disease. The majority of research funding has remained largely dedicated to long-standing, traditional methods of neurodegenerative research and is less inviting of research investigating a potential microbial link to the disease.
Intriguing evidence suggests Alzheimer’s disease may have a link to infectious diseases or a microbial mechanism. Could this be the missing link to lead to a cure?
To advance research that could shed light and provide hope to the more than 5.7 million Americans and 47 million people worldwide living with the disease, the IDSA Foundation established the Alzheimer’s Research Grant, now known as the Microbial Pathogenesis in Alzheimer’s Disease Grant, in 2018 to foster further investigation. These grants support research that suggests an infectious agent or microbial community is correlated to Alzheimer’s disease and promotes novel research in the field of microbial triggers for Alzheimer’s disease.
This program began solely as a grant-making endeavor. However, over the past 5 years, it has progressed into an established research community development program that promotes the pathogenic framework and provides support and opportunities for scientific advancement.